AbbVie Inc.
USD254.31
+0.96 (+0.38%)
CEO
Robert A. Michael
IPO Date
2013-01-02
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Open
$253.05
Prev. Close
$253.35
Day Low
$249.20
Day High
$255.96
52W Low
$181.75
52W High
$255.99
Market Cap
$449.31B
Volume
9.30M
| 73.5 |
| 31 Dec 2023 | FY | 62.4% | 9.0% | 46.9% | 3.6% | 5.80 | 0.87 | 56.3 |
| 31 Dec 2022 | FY | 70.0% | 20.4% | 68.6% | 8.5% | 3.72 | 0.96 | 24.2 |
| 31 Dec 2021 | FY | 69.0% | 20.5% | 74.9% | 7.9% | 5.03 | 0.79 | 20.8 |
| 31 Dec 2020 | FY | 66.4% | 10.1% | 35.3% | 3.1% | 6.66 | 0.84 | 38.7 |
| 31 Dec 2019 | FY | 77.6% | 23.7% | -96.5% | 8.8% | -8.21 | 3.18 | 16.6 |
| 31 Dec 2018 | FY | 76.4% | 17.4% | -67.3% | 9.6% | -4.77 | 0.98 | 25.0 |
| 31 Dec 2017 | FY | 75.0% | 18.8% | 104.2% | 7.5% | 7.33 | 1.28 | 29.1 |
| 31 Dec 2016 | FY | 77.2% | 23.2% | 128.4% | 9.0% | 7.95 | 1.65 | 17.1 |
| 56.0 |
| 30 Sept 2025 | Q3 | 66.4% | 1.2% | -7.0% | 0.1% | -26.02 | 0.72 | 551.5 |
| 30 Jun 2025 | Q2 | 71.8% | 6.1% | -512.6% | 0.7% | -385.14 | 0.74 | 87.7 |
| 31 Mar 2025 | Q1 | 70.0% | 9.6% | 90.6% | 0.9% | 49.22 | 0.76 | 72.0 |
| 31 Dec 2024 | Q4 | 70.9% | -0.1% | -0.7% | -0.0% | 20.40 | 0.66 | -3572.2 |
| 30 Sept 2024 | Q3 | 70.9% | 10.8% | 25.9% | 1.1% | 11.78 | 0.65 | 55.9 |
| 30 Jun 2024 | Q2 | 70.9% | 9.5% | 20.2% | 1.0% | 10.42 | 0.81 | 55.0 |
| 31 Mar 2024 | Q1 | 66.7% | 11.1% | 17.1% | 0.9% | 9.24 | 0.94 | 58.4 |
| 31 Dec 2023 | Q4 | 60.1% | 5.7% | 7.9% | 0.6% | 5.80 | 0.87 | 83.2 |